Evaluation and comparison of impedance and amplitude changes in lesion index-guided pulmonary vein isolation.

ablation atrial fibrillation impedance drop lesion index pulmonary vein isolation

Journal

Journal of arrhythmia
ISSN: 1880-4276
Titre abrégé: J Arrhythm
Pays: Japan
ID NLM: 101263026

Informations de publication

Date de publication:
Feb 2024
Historique:
received: 19 05 2023
revised: 29 10 2023
accepted: 19 11 2023
medline: 9 2 2024
pubmed: 9 2 2024
entrez: 9 2 2024
Statut: epublish

Résumé

The lesion index (LSI) has been used to estimate lesion formation after radiofrequency catheter ablation. However, the impedance drop and decrease in bipolar amplitude of intracardiac electrograms, which are parameters that are traditionally used to predict effective ablation lesions, are not used to calculate LSI. Therefore, we aimed to investigate the association between LSI and traditional parameters. We retrospectively investigated 1355 ablation points from 31 patients who underwent LSI-guided pulmonary vein isolation (PVI) using TactiCath. All points were classified into 3 groups based on the impedance drop: (i) <10 Ω ( The target LSI was achieved at 1177 points (86.9%). The median total impedance drop and amplitude just after ablation were 16.0 [13.0-20.0] Ω and 0.21 [0.14-0.30] mV, respectively. There were significant differences among the 3 groups in the impedance and amplitude before ablation, power, target LSI, final LSI, contact force, and interlesion distance. An impedance drop of >10 Ω or an amplitude reduction of >50% was achieved at 95% and 82% of the study points, respectively. There were no major complications at any of the ablation points. LSI-guided PVI seemed to be useful for making sufficient ablation lesions, as assessed by the conventional parameters of impedance and amplitude change.

Sections du résumé

Background UNASSIGNED
The lesion index (LSI) has been used to estimate lesion formation after radiofrequency catheter ablation. However, the impedance drop and decrease in bipolar amplitude of intracardiac electrograms, which are parameters that are traditionally used to predict effective ablation lesions, are not used to calculate LSI. Therefore, we aimed to investigate the association between LSI and traditional parameters.
Methods UNASSIGNED
We retrospectively investigated 1355 ablation points from 31 patients who underwent LSI-guided pulmonary vein isolation (PVI) using TactiCath. All points were classified into 3 groups based on the impedance drop: (i) <10 Ω (
Results UNASSIGNED
The target LSI was achieved at 1177 points (86.9%). The median total impedance drop and amplitude just after ablation were 16.0 [13.0-20.0] Ω and 0.21 [0.14-0.30] mV, respectively. There were significant differences among the 3 groups in the impedance and amplitude before ablation, power, target LSI, final LSI, contact force, and interlesion distance. An impedance drop of >10 Ω or an amplitude reduction of >50% was achieved at 95% and 82% of the study points, respectively. There were no major complications at any of the ablation points.
Conclusion UNASSIGNED
LSI-guided PVI seemed to be useful for making sufficient ablation lesions, as assessed by the conventional parameters of impedance and amplitude change.

Identifiants

pubmed: 38333375
doi: 10.1002/joa3.12966
pii: JOA312966
pmc: PMC10848590
doi:

Types de publication

Journal Article

Langues

eng

Pagination

100-108

Informations de copyright

© 2023 The Authors. Journal of Arrhythmia published by John Wiley & Sons Australia, Ltd on behalf of Japanese Heart Rhythm Society.

Déclaration de conflit d'intérêts

Authors declare no conflict of interests for this article.

Auteurs

Yutaro Kaneko (Y)

Division of Cardiology, Department of Internal Medicine III Hamamatsu University School of Medicine Hamamatsu Japan.

Yoshihisa Naruse (Y)

Division of Cardiology, Department of Internal Medicine III Hamamatsu University School of Medicine Hamamatsu Japan.

Taro Narumi (T)

Division of Cardiology, Department of Internal Medicine III Hamamatsu University School of Medicine Hamamatsu Japan.

Makoto Sano (M)

Division of Cardiology, Department of Internal Medicine III Hamamatsu University School of Medicine Hamamatsu Japan.

Tsuyoshi Urushida (T)

Division of Cardiology, Department of Internal Medicine III Hamamatsu University School of Medicine Hamamatsu Japan.

Yuichiro Maekawa (Y)

Division of Cardiology, Department of Internal Medicine III Hamamatsu University School of Medicine Hamamatsu Japan.

Classifications MeSH